Axillary vs sentinel lymph node dissectionfor invasive breast cancer [2]
Journal
JAMA - Journal of the American Medical Association
Journal Volume
305
Journal Issue
22
Pages
2288-2289
Date Issued
2011
Author(s)
SDGs
Other Subjects
antineoplastic agent; axillary lymph node extirpation; breast cancer; cancer adjuvant therapy; cancer recurrence; clinical practice; clinical trial (topic); disease free survival; human; intermethod comparison; letter; lymph node dissection; lymph node metastasis; optimal drug dose; overall survival; postoperative care; priority journal; recurrence free survival; sentinel lymph node dissection; sentinel lymph node metastasis; surgical approach; survival; adjuvant chemotherapy; axilla; breast tumor; drug administration; female; lymphadenectomy; note; reproducibility; sentinel lymph node biopsy; time; treatment outcome; Axilla; Breast Neoplasms; Chemotherapy, Adjuvant; Clinical Trials as Topic; Disease-Free Survival; Drug Administration Schedule; Female; Humans; Lymph Node Excision; Reproducibility of Results; Sentinel Lymph Node Biopsy; Time Factors; Treatment Outcome
Type
letter